- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Relapsed or refractory multiple myeloma
Total 214627 results
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Duke UniversityGlaxoSmithKlineCompletedMultiple MyelomaUnited States
-
Janssen-Cilag Ltd.Legend BiotechCompletedMultiple MyelomaBelgium, United States, United Kingdom, Italy, Germany, Netherlands, Spain, France, Russian Federation, Poland
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Bristol-Myers SquibbActive, not recruiting
-
Cancer Trials IrelandBristol-Myers Squibb; Janssen PharmaceuticalsActive, not recruiting
-
CelgeneActive, not recruitingMultiple MyelomaAustria
-
TeneoOne Inc.AbbVieActive, not recruitingMultiple MyelomaUnited States, Germany
-
LaNova Medicines LimitedWithdrawnRelapsed or Refractory Multiple Myeloma | Other Plasma Cell Diseases
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
GlaxoSmithKlineActive, not recruiting
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncTerminatedRefractory Multiple Myeloma | Myeloma | Myeloma MultipleUnited States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; Celgene Corporation; University... and other collaboratorsCompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States
-
AbbVieCompletedMultiple Myeloma (MM)United States, Argentina, Australia, Brazil, Canada, Croatia, Czechia, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovenia, Spain, Taiwan, Turkey
-
BeBetter Med IncCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Non-Hodgkin's LymphomaChina
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
GWT-TUD GmbHActive, not recruitingRefractory Multiple MyelomaGermany
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); City of Hope Medical Center and other collaboratorsCompletedRecurrent Plasma Cell MyelomaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Denmark, Australia, Belgium, Finland, Greece, Japan, Korea, Republic of, Spain, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Non-Secretory Plasma Cell Myeloma | PlasmacytosisUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
SanofiTerminatedPlasma Cell MyelomaTaiwan, United States, Czechia, France, Greece, Spain
-
Precision BioSciences, Inc.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Juno Therapeutics, Inc.CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of NebraskaM.D. Anderson Cancer CenterTerminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaMultiple Myeloma | Refractory Multiple Myeloma | Relapsed/Refractory Multiple MyelomaUnited States
-
SanofiCompleted
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Andrew Yee, MDBristol-Myers Squibb; Takeda Pharmaceuticals North America, Inc.TerminatedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
University of Southern CaliforniaNational Cancer Institute (NCI); Oncolytics BiotechCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.Completed
-
AstraZenecaTerminatedLymphoma | Multiple Myeloma | Advanced Solid Tumors | Hematologic MalignanciesUnited States
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
AbbVieActive, not recruitingMultiple MyelomaUnited States, France, Germany, Italy, Japan, Spain
-
Regeneron PharmaceuticalsActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
TakedaCompletedMultiple MyelomaUnited States, Netherlands, Czechia, France, Greece, Poland
-
European Myeloma NetworkUniversity of Turin, ItalyCompleted
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; State University of New York -... and other collaboratorsActive, not recruiting
-
Fondazione EMN Italy OnlusCompleted